BIOHIT'S FINANCIAL STATEMENTS AND REPORT OF BOARD OF DIRECTORS HAVE BEEN
BIOHIT OYJ STOCK EXCHANGE RELEASE 31 MARCH 2009 AT 6:55 PM
BIOHIT'S FINANCIAL STATEMENTS AND REPORT OF BOARD OF DIRECTORS HAVE BEEN
PUBLISHED
The financial statements, the report of the Board of Directors and the auditor's
report of Biohit Oyj for the financial year 2008 have been published today in
Finnish and English. They are available in pdf format on Biohit's web site at
www.biohit.com/investors.
The Annual Report 2008, which also includes the financial statements, the report
of the Board of Directors and the auditor's report, will be published in Finnish
and English on Biohit's web site during week 16 the latest.
Hardcopies of the Annual Report may be ordered from Biohit, via telephone:
+358-9-7738 61, via email info@biohit.com or via the order form at Biohit's
website.
ANNUAL SUMMARY OF STOCK EXCHANGE RELEASES
An annual summary of Biohit Oyj's stock exchange releases and announcements
published in 2008 is available at www.biohit.com/exreleases. Additionally, the
summary is published in the Annual Report. The website also includes all other
stock exchange releases and announcements published by Biohit since 1999.
Some of the information included in the releases might be out of date.
Biohit Oyj
Further information:
Osmo Suovaniemi, M.D., Ph.D., Professor
President & CEO
Tel: +358-9-773 861
GSM: +358-40-745 5605
Email: osmo.suovaniemi@biohit.com
Distribution:
NASDAQ OMX Helsinki Oy
Central storage facility (www.oam.fi)
Press
www.biohit.com
About Biohit Oyj
Biohit Oyj develops, manufactures and markets liquid handling products and
diagnostic test systems for use in research, health care and industrial
laboratories.
Liquid handling products include electronic and mechanical pipettes and
dispensers, and disposable tips, as well as pipette maintenance and calibration
services. Diagnostics business comprises products and analysis systems for
diagnosing, screening and prevention of gastrointestinal diseases, e.g. the
blood-sample based GastroPanel and GastroView, for diagnosing diseases of the
stomach and associated risks, as well as quick tests for the diagnosis of
lactose intolerance, H. pylori infection and fecal occult blood.
Biohit Oyj is headquartered in Finland. Biohit has subsidiaries in France,
Germany, the UK, Russia, China, Japan and the USA. Additionally, Biohit's
products are sold by approximately 450 distributors in 70 countries. Biohit's
share (BIOBV) is quoted on NASDAQ OMX Helsinki.
Read more at www.biohit.com
